Clinical Trials Directory

Trials / Completed

CompletedNCT02407548

The Effects of Dietary Supplement of Coenzyme Q10(CoQ10) on Dyslipidemia

The Effects of Dietary Supplement of Coenzyme Q10 on Dyslipidemia

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
150 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In previous study the investigators found that CoQ10 can improve cholesterol efflux from macrophages in cell model, ApoE mice model and small-scale of healthy volunteers. In addition, CoQ10 has strong antioxidant activity and is an essential factor of mitochondria electron transport chain. So the investigators hypothesize that CoQ10 may have some health promotion effect on dyslipidemia, risk factor of atherosclerosis and other cardiovascular diseases. On this purpose, the investigators are going to recruit 150 dyslipidemia patients to supply CoQ10+vitamin E or CoQ10 alone or placebo in different doses for 24 weeks to explore the effects of CoQ10 on cholesterol efflux and lipid profiles on dyslipidemia.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTcoenzyme Q10 vitamin E softgel4 coenzyme Q10 and vitamin E softgels per day for 24 weeks. Keep normal lift style unchanged.
DIETARY_SUPPLEMENTcoenzyme Q10 softgel4 coenzyme Q10 softgels per day for 24 weeks. Keep normal lift style unchanged.
DIETARY_SUPPLEMENTplacebo softgel4 placebo softgels per day. Keep normal lift style unchanged.

Timeline

Start date
2015-07-01
Primary completion
2017-04-01
Completion
2017-04-01
First posted
2015-04-03
Last updated
2017-06-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02407548. Inclusion in this directory is not an endorsement.